China 
Africa 
Explore chapters and articles related to this topic
Environmental Protection
Published in Lawrence S. Chan, William C. Tang, Engineering-Medicine, 2019
in a chronic disease called “medication overuse headache” associated with documented abnormal brain structure and function (Symvoulakis et al. 2015, Schwedt and Chong 2017). To achieve this reduction, there is a great need for evidence-based medical publications which provide solid evidences of proper treatments and non-treatments. Such evidence-based medical information will greatly help healthcare professionals in making appropriate medication decision and to avoid prescribing unneeded medications. Artificial intelligence, particularly machine learning, will likely be a great help in this regard.
Device profile of Nerivio for the acute and preventive treatment of episodic or chronic migraine in patients 12 years and older
Published in Expert Review of Medical Devices, 2023
Mahsa Babaei, Alan M. Rapoport
Currently, medications are the first-line therapy for the acute and preventive treatment of migraine headache, where there is always a risk for adverse effects, medication intolerance and development of Medication Overuse Headache (MOH). MOH is associated with frequent use, over 3 months or longer, of acute care agents other than the newer small molecule CGRP receptor blockers (gepants) [23,48]. Nerivio provides acute and preventive (‘dual use’) migraine treatment without this risk, nor risks of addiction or pharmacological adverse effects [13]. Moreover, due to the rapid beneficial effect of the device for migraine treatment, there is better patient adherence, compliance, and quality of life, compared with pharmacological agents [23,48]. Several studies, including controlled clinical trials and real-world evidence, have documented the efficacy, tolerability, and safety of Nerivio [13]. The REN technology has shown significant superiority over NSAIDs for pain relief and the clinical efficacy of Nerivio has been shown to be comparable to prescribed migraine medications [54, 55–58].